Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia

MLA

Yohei Doi, et al. “Renoprotection by Long‐term Low‐dose Tolvaptan in Patients with Heart Failure and Hyponatremia.” ESC Heart Failure, vol. 8, no. 6, Sept. 2021, pp. 4904–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0b71746fa00572fb125b50ab7ae882fe&authtype=sso&custid=ns315887.

APA

Yohei Doi, Karin Shimada, Yusuke Sakaguchi, Tomohito Ohtani, Yasushi Sakata, Fusako Sera, Shungo Hikoso, Takayuki Hamano, Masamitsu Senda, Satoshi Yamaguchi, Kei Nakamoto, Yoshitaka Isaka, Tatsufumi Oka, Nobuhiro Hashimoto, Ayumi Matsumoto, & Isao Matsui. (2021). Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia. ESC Heart Failure, 8(6), 4904–4914.

Chicago

Yohei Doi, Karin Shimada, Yusuke Sakaguchi, Tomohito Ohtani, Yasushi Sakata, Fusako Sera, Shungo Hikoso, et al. 2021. “Renoprotection by Long‐term Low‐dose Tolvaptan in Patients with Heart Failure and Hyponatremia.” ESC Heart Failure 8 (6): 4904–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0b71746fa00572fb125b50ab7ae882fe&authtype=sso&custid=ns315887.